Skip to content

Effectiveness of Homoeopathic Medicines in cases of Varicose Veins.

Effectiveness of Individualized Homoeopathic Medicines in the Management of Chronic Venous Diseases: An Exploratory Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077646
Enrollment
35
Registered
2024-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I872- Venous insufficiency (chronic) (peripheral)

Interventions

Intervention1: Homoeopathic Medicine: Oral route of administration pill form 30 number pill size centesimal scale First dose after case taking and subsequent doses after each follow up and potency acc

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants presented between C0 and C6 according to CEAP clinical rating. Participants presenting with visible varicose veins with varicose or stasis eczema, varicose ulcers, itching, pain, heaviness, numbness, and swelling in lower limbs. Age above 18 All genders.

Exclusion criteria

Exclusion criteria: Pregnancy, lactating mother, secondary causes of chronic venous disease or varicose veins (abdominal tumors). Any participants presenting with deep vein thrombosis, thrombophlebitis, severe systemic illness, immunocompromised, under the influence of substance abuse, and any psychiatric illness. Participants who need surgical intervention. Participants who refuse to give consent. Participants who are under any other sort of treatment.

Design outcomes

Primary

MeasureTime frame
Decrease in total score of Revised VCSS will signify improvement in signs and symptoms of chronic venous disease.Timepoint: Revised Venous clinical severity score will be evaluated at Baseline, 4 weeks, 8 weeks, 12 weeks till 24 weeks Study Duration 15 months Enrollment period (6 months) Follow-up duration (6 months) Data analysis and report writing (3 months) First dose will be given after case taking and

Secondary

MeasureTime frame
Improvement in participant quality of life score as measured by validated CIVIQ-20. Timepoint: Quality of life assessment will be done using the CIVIQ-20 questionnaire at Baseline, 4 weeks, 8 weeks, 12 weeks till 24 weeks Study Duration 15 months Enrollment period (6 months) Follow-up duration (6 months) Data analysis and report writing (3 months)

Countries

India

Contacts

Public ContactDr Ashwini Nair

Bakson Homoeopathic Medical College And Hospital

pginchargebakson@gmail.com9990178024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026